Vir Biotechnology, Inc. (VIR) — Stock Score Summary

Vir Biotechnology, Inc. (VIR) has a MoatMap StockRank of 53/100 based on Quality (37/100), Value (39/100), and Momentum (64/100) factor scores. The current signal is HOLD. Biotech firm with a large cash pile but highly speculative pipeline, failing our requirement for predictable, high-ROIC compounders.

Vir Biotechnology, Inc. is a clinical-stage immunology company focused on combining immunologic insights with cutting-edge technologies to develop novel solutions for serious infectious diseases. Its competitive moat lies in its proprietary technology platforms, including antibody engineering, T cell therapy, and in vivo gene editing, aimed at generating best-in-class therapies. Vir is a specialized biopharmaceutical firm, positioned at the forefront of infectious disease research and development.

Key Financial Metrics

Price$8.51
Market Cap$1.6B
P/E (Forward)-3.94
Price/Book1.67
Return on Equity-47.7%
Return on Invested Capital-52.7%
Debt/Equity11.76
Gross Margin0.0%
Operating Margin459241.4%
Free Cash Flow$-215M

Vir Biotechnology, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Vir Biotechnology, Inc.’s (VIR) StockRank?
MoatMap’s StockRank for Vir Biotechnology, Inc. (VIR) is 53/100, with a Hold signal. It is a composite of Quality (37), Value (39), and Momentum (64) factor ranks across MoatMap’s 19,000+ stock universe.
Does Vir Biotechnology, Inc. have an economic moat?
Vir Biotechnology, Inc. (VIR) has a Quality factor score of 37/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Vir Biotechnology, Inc. a buy, hold, or sell?
MoatMap’s current signal for Vir Biotechnology, Inc. (VIR) is Hold, based on a StockRank of 53/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Vir Biotechnology, Inc. in?
Vir Biotechnology, Inc. (VIR) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksVIR deep dive reportAI ChampionsHow we score stocksSense-check another stock